Skip to main content

Conference Insider

First Report Managed Care
While the correlation between musculoskeletal symptoms, patient-reported outcomes, and ultrasonography findings is poor in patients with psoriasis with suspected psoriatic arthritis (PsA), musculoskeletal ultrasonography (MSK-US) provides additional information for clinical assessment and aids in…
First Report Managed Care
Alcohol consumption can predict progression of spinal structural damage in axial spondyloarthritis (axSpA), according to findings from a new study presented at the 2019 American College of Rheumatology (ACR)/Association of Rheumatology Professionals (ARP) Annual Meeting.
First Report Managed Care
Achieving remission in psoriatic arthritis (PsA) is important to prevent further structural damage, especially among patients who have preexisting structural changes, according to new research presented at the 2019 American College of Rheumatology (ACR)/Association of Rheumatology Professionals (…
First Report Managed Care
Using 3-tesla magnetic resonance imaging (3T MRI) to assess for changes of the flexor tendon pulleys may aid in the detection and monitoring of psoriatic arthritis (PsA), according to a new study presented at the 2019 American College of Rheumatology (ACR)/Association of Rheumatology Professionals…
First Report Managed Care
In patients with axial spondyloarthritis (axSpA), sacroiliac joint (SIJ) inflammation based on magnetic resonance imaging (MRI) findings and smoking are strongly associated with manual labor jobs or low education level, according to results of a new study presented at the 2019 American College of…
First Report Managed Care
In patients taking a tumor necrosis factor inhibitor (TNFi), the live attenuated varicella zoster vaccine (ZV) did not induce varicella infection or reactivation during the 6-week risk period following vaccination, according to results of a new study presented at the 2019 American College of…
First Report Managed Care
Study results being presented at the 2019 ASH Annual Meeting & Exposition suggest that combining perioperative iron with blood optimization compound (BOC) can lead to improved patient outcomes.
First Report Managed Care
Data being presented at the 2019 ASH Annual Meeting & Exposition show front-line ibrutinib therapy plus rituximab as having a high efficacy rate in patients with indolent clinical forms of mantle cell lymphoma (MCL).
First Report Managed Care
Compared with those with private insurance, participants in breast cancer clinical trials with Medicare, Medicaid, or other government insurance were less likely to complete trials and had a lower survival rate.
First Report Managed Care
Most clinical trials supporting US Food and Drug Administration approval of drugs for metastatic breast cancer over the past 13 years did not meet thresholds for substantial clinical benefit on two of three established measures, according to research presented at the San Antonio Breast Cancer…
Back to Top